CHEK1 and cancer: More specifically, CHEK1 germline and somatic mutations have been observed in cancers such as breast, endometrial, colorectal and stomach, and germline mutations within ATR have been linked to an increased risk of developing oropharyngeal cancer and other malignancies [127,128,129,130,131,132,133,134].